Rigel Pharmaceuticals

After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel
Fierce Pharma
Thu, 02/22/24 - 11:40 am
Rigel Pharmaceuticals
Gavreto
RET inhibitors
Blueprint Medicines
Roche
Rigel’s Rezlidhia (olutasidenib) Gets FDA Approval for Relapsed or Refractory AML
Xtalks
Wed, 12/7/22 - 09:53 am
Rigel Pharmaceuticals
Rezlidhia
olutasidenib
FDA
AML
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA
Fierce Biotech
Tue, 08/2/22 - 11:30 pm
Rigel Pharmaceuticals
Forma Therapeutics
olutasidenib
leukemia
FDA
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
Tue, 11/16/21 - 11:57 am
restructuring
Rigel Pharmaceuticals
Zymergen
Esperion Therapeutics
Amarin
Theravance
Sanofi
Acorda Therapeutics
CureVac
Ziopharm Oncology
Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?
Motley Fool
Thu, 08/26/21 - 11:02 am
Rigel Pharmaceuticals
Emergency Use Authorization
FDA
Tavalisse
COVID-19
FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data
Fierce Pharma
Fri, 08/13/21 - 10:57 am
Rigel Pharmaceuticals
Tavalisse
COVID-19
FDA
Catalyst, Zogenix, Rigel and Pfizer kick off pharma's July price hikes: report
Fierce Pharma
Thu, 07/1/21 - 10:22 pm
drug pricing
Pfizer
Zogenix
Rigel Pharmaceuticals
Catalyst Pharmaceuticals
Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems
BioPharma Dive
Thu, 02/18/21 - 10:05 pm
Eli Lilly
Rigel Pharmaceuticals
autoimmune disease
inflammatory disease
Rigel enrolls first patients in phase 2 Covid-19 trial of fostamatinib
Pharmaceutical Business Review
Mon, 10/12/20 - 10:37 am
Rigel Pharmaceuticals
clinical trials
fostamatinib
COVID-19
Why Rigel Pharmaceuticals Stock Skyrocketed 91% Today
Motley Fool
Tue, 07/14/20 - 11:26 pm
COVID-19 pneumonia
Rigel Pharmaceuticals
clinical trials
fostamatinib
2 Biotechs Battling Immune Diseases
Motley Fool
Sun, 01/19/20 - 07:41 pm
Rigel Pharmaceuticals
Momenta Pharmaceuticals
autoimmune disease
biologics
small molecule drugs
Rigel Announces Pricing Of Common Stock Offering
CP Wire
Thu, 04/19/18 - 11:48 pm
Rigel Pharmaceuticals
stock offering
Rigel Announces Pricing Of Common Stock Offering
Thu, 04/19/18 - 09:37 pm
Rigel Pharmaceuticals
Rigel Proposes Stock Offering on Heels of Tavalisse Approval
CP Wire
Thu, 04/19/18 - 12:28 am
Rigel Pharmaceuticals
stock offering
Tavalisse
Rigel Proposes Stock Offering on Heels of Tavalisse Approval
Wed, 04/18/18 - 05:31 pm
Rigel Pharmaceuticals
FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults
CP Wire
Wed, 04/18/18 - 11:31 am
Rigel Pharmaceuticals
Tavalisse
chronic immune thrombocytopenia
FDA
FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults
Wed, 04/18/18 - 12:13 am
Rigel Pharmaceuticals
Tavalisse
chronic immune thrombocytopenia
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers
Bizjournals.com
Thu, 02/26/15 - 03:04 pm
Rigel Pharmaceuticals
Bristol-Myers Squibb
Rigel experimental eye drug fails mid-stage study
Yahoo/Reuters
Wed, 08/13/14 - 08:23 am
Rigel Pharmaceuticals
R348
dry eye disease

Pages